Since Bevacizumab has been successfully used for inhibiting VEGF signaling in immunocompetent mice 30-33, we used this tool to mimic our results of Snail1 depletion in the MMTV-PyMT breast tumor model. Here, SNAI1 is linked to breast neoplasm.